Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD
- 1 January 1997
- journal article
- Published by Elsevier in Kidney International
- Vol. 51 (1), 182-186
- https://doi.org/10.1038/ki.1997.22
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPDKidney International, 1994
- Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failureThe Lancet, 1994
- Advanced Glycosylation End Products in Continuous Ambulatory Peritoneal Dialysis PatientsAmerican Journal of Kidney Diseases, 1993
- Advanced Glycosylation End Products in Patients with Diabetic NephropathyNew England Journal of Medicine, 1991
- Immunochemical approach to characterize advanced glycation end products of the Maillard reactionPublished by Elsevier ,1991
- Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties.The Journal of Experimental Medicine, 1989
- Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue RemodelingScience, 1988
- Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-LinkingScience, 1986
- Accelerated age-related browning of human collagen in diabetes mellitus.Proceedings of the National Academy of Sciences, 1984